Faysal Md, Zehravi Mehrukh, Sutradhar Baishakhi, Al Amin Md, Shanmugarajan Thukani Sathanantham, Arjun Uppuluri Varuna Naga Venkata, Ethiraj Susithra, Durairaj Akiladevi, Dayalan Girija, Ahamad Shaik Khadeer, Rab Safia Obaidur, Raman Kannan, Emran Talha Bin
Department of Pharmacy, Faculty of Health and Life Sciences, Daffodil International University, Dhaka, Bangladesh.
Department of Clinical Pharmacy, College of Dentistry & Pharmacy, Buraydah Private Colleges, Buraydah, Saudi Arabia.
CNS Neurosci Ther. 2025 Sep;31(9):e70593. doi: 10.1111/cns.70593.
The microbiota-gut-brain axis (MGBA), a complex two-way connection between the gut microbiota and the brain, has become a key regulator of neurological and neuropsychiatric disorders. Neurological disorders and gut microbiota dysbiosis are linked to these diseases. Changes in gut microbiota can lead to neurotransmitter imbalances, oxidative stress, and neuroinflammation. Gut dysbiosis may contribute to the development of diseases such as depression, autism, schizophrenia, bipolar disorder, Parkinson's disease, Alzheimer's disease, dementia, multiple sclerosis, epilepsy, anxiety, and autism spectrum disorders through immunological regulation, neuroinflammation, and neurotransmitter metabolism changes.
This review systematically sourced articles related to microbiota gut brain axis, neurological disorders, neuropsychiatric disorders and clinical studies from major medical databases, including Scopus, PubMed, and Web of Science.
This review explores the molecular processes underlying MGBA interactions, including vagus nerve signaling, systemic immunological responses, and metabolites produced by microorganisms. The discussion explores the potential of microbiome-targeted treatments like fecal microbiota transplantation, probiotics, and prebiotics as effective treatment methods. The comprehension of the MGBA can revolutionize neurology and psychiatry, introducing innovative diagnostic and therapeutic approaches. Multiple elements, including diet, metabolism, age, stress, and medications, shape the human gut microbiota, and intestinal imbalances can lead to CNS diseases. The MGBA interacts with gut bacteria, and gut dysbiosis is associated with neurological disorders.
The review demonstrates the correlation between gut microbiota and neurologically associated diseases, highlighting its importance in neurogenesis, mental development, emotions, and behaviors. MGBA, mediated by microbial metabolites, affects brain function and neuroinflammation. Interventions like fetal microbiota transplantation, probiotics, and prebiotics can improve microbial balance, but more clinical research is needed.
微生物群-肠-脑轴(MGBA)是肠道微生物群与大脑之间复杂的双向连接,已成为神经和神经精神疾病的关键调节因子。神经疾病和肠道微生物群失调与这些疾病相关。肠道微生物群的变化可导致神经递质失衡、氧化应激和神经炎症。肠道菌群失调可能通过免疫调节、神经炎症和神经递质代谢变化,导致抑郁症、自闭症、精神分裂症、双相情感障碍、帕金森病、阿尔茨海默病、痴呆症、多发性硬化症、癫痫、焦虑症和自闭症谱系障碍等疾病的发生。
本综述系统地从主要医学数据库(包括Scopus、PubMed和Web of Science)中检索与微生物群-肠-脑轴、神经疾病、神经精神疾病和临床研究相关的文章。
本综述探讨了MGBA相互作用的分子过程,包括迷走神经信号传导、全身免疫反应和微生物产生的代谢产物。讨论探讨了粪菌移植、益生菌和益生元等针对微生物群的治疗方法作为有效治疗手段的潜力。对MGBA的理解可以彻底改变神经病学和精神病学,引入创新的诊断和治疗方法。饮食、代谢、年龄、压力和药物等多种因素塑造了人类肠道微生物群,肠道失衡可导致中枢神经系统疾病。MGBA与肠道细菌相互作用,肠道菌群失调与神经疾病相关。
本综述证明了肠道微生物群与神经相关疾病之间的相关性,强调了其在神经发生、心理发展、情绪和行为中的重要性。由微生物代谢产物介导的MGBA影响脑功能和神经炎症。胎儿微生物群移植、益生菌和益生元等干预措施可以改善微生物平衡,但还需要更多的临床研究。